Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PWON.JK Stock Summary
In the News
PWON.JK Financial details
Company Rating
Buy
Market Cap
20804.95B
Income
2105.21B
Revenue
6200.44B
Book val./share
396.53
Cash/share
173.69
Dividend
6.5
Dividend %
1.46%
Employees
3.03K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
11.66
Forward P/E
-
PEG
3.17
P/S
3.53
P/B
1.16
P/C
2.26
P/FCF
25.94
Quick Ratio
3.24
Current Ratio
4.7
Debt / Equity
0.32
LT Debt / Equity
0.27
-
-
EPS (TTM)
43.7
EPS next Y
-
EPS next Q
-
EPS this Y
36.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.99%
Revenue last 5Y
-2.95%
Revenue Q/Q
-2.48%
EPS Q/Q
59.18%
-
-
-
-
SMA20
1.96%
SMA50
-3.03%
SMA100
1.22%
Inst Own
0%
Inst Trans
0%
ROA
6%
ROE
10%
ROC
0.09%
Gross Margin
56%
Oper. Margin
41%
Profit Margin
30%
Payout
17%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
392.0-525.0
52W High
-25.33%
52W Low
0%
RSI
36
Rel Volume
2.24
Avg Volume
28.19M
Volume
63.05M
Perf Week
-8.41%
Perf Month
-4.39%
Perf Quarter
-
Perf Half Y
-6.22%
-
-
-
-
Beta
0.962
-
-
Volatility
13.71%, 9.14%
Prev Close
-2%
Price
392
Change
-3.92%
PWON.JK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 149.54 | 82.58 | 118.63 | 124.32 | 128.75 | |
Net income per share | 56.47 | 19.31 | 28.71 | 31.95 | 43.71 | |
Operating cash flow per share | 36.76 | 29.47 | 46.48 | 33.09 | 56.77 | |
Free cash flow per share | 20.53 | 22.38 | 43.72 | 23.2 | 40.28 | |
Cash per share | 90.93 | 68.08 | 133.9 | 161.95 | 173.69 | |
Book value per share | 310.87 | 303.9 | 333.2 | 359.38 | 396.53 | |
Tangible book value per share | 375.74 | 365.42 | 398.23 | 430.2 | 473.33 | |
Share holders equity per share | 310.87 | 303.9 | 333.2 | 359.38 | 396.53 | |
Interest debt per share | 104.16 | 86 | 124.9 | 137.13 | 134.73 | |
Market cap | 27450.97B | 24561.4B | 22346.06B | 21960.78B | 21864.46B | |
Enterprise value | 27934.38B | 25618.51B | 21609.25B | 20793.43B | 20389.61B | |
P/E ratio | 10.09 | 26.41 | 16.16 | 14.27 | 10.39 | |
Price to sales ratio | 3.81 | 6.18 | 3.91 | 3.67 | 3.53 | |
POCF ratio | 15.51 | 17.31 | 9.98 | 13.78 | 8 | |
PFCF ratio | 27.76 | 22.79 | 10.61 | 19.66 | 11.27 | |
P/B Ratio | 1.83 | 1.68 | 1.39 | 1.27 | 1.14 | |
PTB ratio | 1.83 | 1.68 | 1.39 | 1.27 | 1.14 | |
EV to sales | 3.88 | 6.44 | 3.78 | 3.47 | 3.29 | |
Enterprise value over EBITDA | 7.96 | 17.97 | 10.17 | 9.27 | 6.81 | |
EV to operating cash flow | 15.78 | 18.05 | 9.65 | 13.05 | 7.46 | |
EV to free cash flow | 28.25 | 23.77 | 10.26 | 18.61 | 10.51 | |
Earnings yield | 0.1 | 0.04 | 0.06 | 0.07 | 0.1 | |
Free cash flow yield | 0.04 | 0.04 | 0.09 | 0.05 | 0.09 | |
Debt to equity | 0.32 | 0.27 | 0.36 | 0.36 | 0.32 | |
Debt to assets | 0.18 | 0.15 | 0.2 | 0.21 | 0.19 | |
Net debt to EBITDA | 0.14 | 0.74 | -0.35 | -0.52 | -0.49 | |
Current ratio | 2.86 | 1.98 | 3.79 | 4.65 | 5.16 | |
Interest coverage | 15.77 | 6.94 | 6.72 | 6.69 | 6.62 | |
Income quality | 0.65 | 1.53 | 1.62 | 1.04 | 1.3 | |
Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.12 | 0 | 0 | 0.12 | 0.15 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.44 | -0.01 | 0.42 | -0.03 | 0.46 | |
Capex to operating cash flow | -0.44 | -0.24 | -0.06 | -0.3 | -0.29 | |
Capex to revenue | -0.11 | -0.09 | -0.02 | -0.08 | -0.13 | |
Capex to depreciation | -1.56 | -0.62 | -0.21 | -8.68 | -1.13 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 628.47 | 363.36 | 463.92 | 508.3 | 624.5 | |
ROIC | 0.17 | 0.07 | 0.09 | 0.09 | 0.09 | |
Return on tangible assets | 0.19 | 0.03 | 0.08 | 0.05 | 0.12 | |
Graham Net | -23.96 | -65.34 | -22.01 | -0.48 | 15.17 | |
Working capital | 6269.49B | 4253.33B | 8434.06B | 9619.97B | 10523.29B | |
Tangible asset value | 6666.93B | 17906.94B | 7042.59B | 21745.88B | 7757.62B | |
Net current asset value | 1643.08B | -270.09B | 1765.4B | 2369.56B | 3139.97B | |
Invested capital | 0.32 | 0.27 | 0.36 | 0.36 | 0.32 | |
Average receivables | 467.24B | 586.41B | 245B | 240.14B | 245.35B | |
Average payables | 314.92B | 340.81B | 281.43B | 214.06B | 206.82B | |
Average inventory | 3553.68B | 4021.54B | 4246.35B | 3880.08B | 3974.31B | |
Days sales outstanding | 47.36 | 21.87 | 16.08 | 13.94 | 15.43 | |
Days payables outstanding | 38.78 | 62.3 | 26.65 | 28.06 | 25.64 | |
Days of inventory on hand | 409.92 | 808.75 | 492.66 | 498.25 | 532.32 | |
Receivables turnover | 7.71 | 16.69 | 22.7 | 26.19 | 23.66 | |
Payables turnover | 9.41 | 5.86 | 13.7 | 13.01 | 14.24 | |
Inventory turnover | 0.89 | 0.45 | 0.74 | 0.73 | 0.69 | |
ROE | 0.18 | 0.06 | 0.09 | 0.09 | 0.11 | |
Capex per share | -16.23 | -7.09 | -2.77 | -9.89 | -16.5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 30.98 | 28.75 | 31.4 | 34.73 | 33.87 | |
Net income per share | 7.21 | 12.36 | 10.45 | 8.06 | 12.83 | |
Operating cash flow per share | 7.69 | 12.36 | 8.97 | 17.19 | 13.82 | |
Free cash flow per share | 0.77 | 9.66 | 7.09 | 8.58 | 10.52 | |
Cash per share | 161.95 | 162.93 | 159.97 | 156.43 | 173.69 | |
Book value per share | 359.38 | 371.69 | 376.17 | 384.4 | 396.53 | |
Tangible book value per share | 430.2 | 443.81 | 449.93 | 459.81 | 473.33 | |
Share holders equity per share | 359.38 | 371.69 | 376.17 | 384.4 | 396.53 | |
Interest debt per share | 132.08 | 126.46 | 126.22 | 130.47 | 129.7 | |
Market cap | 21960.78B | 21864.46B | 23501.89B | 21093.91B | 21864.46B | |
Enterprise value | 20793.43B | 20408.25B | 22191.2B | 20143.72B | 20389.61B | |
P/E ratio | 15.8 | 9.18 | 11.67 | 13.58 | 8.84 | |
Price to sales ratio | 14.72 | 15.79 | 15.54 | 12.61 | 13.4 | |
POCF ratio | 59.29 | 36.72 | 54.37 | 25.48 | 32.85 | |
PFCF ratio | 593.85 | 47 | 68.87 | 51.05 | 43.14 | |
P/B Ratio | 1.27 | 1.22 | 1.3 | 1.14 | 1.14 | |
PTB ratio | 1.27 | 1.22 | 1.3 | 1.14 | 1.14 | |
EV to sales | 13.94 | 14.74 | 14.68 | 12.04 | 12.5 | |
Enterprise value over EBITDA | 37.76 | 26.38 | 31.7 | 36.62 | 26.54 | |
EV to operating cash flow | 56.13 | 34.28 | 51.34 | 24.33 | 30.63 | |
EV to free cash flow | 562.28 | 43.87 | 65.03 | 48.75 | 40.23 | |
Earnings yield | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0 | 0.02 | 0.01 | 0.02 | 0.02 | |
Debt to equity | 0.36 | 0.34 | 0.33 | 0.33 | 0.32 | |
Debt to assets | 0.21 | 0.19 | 0.19 | 0.19 | 0.19 | |
Net debt to EBITDA | -2.12 | -1.88 | -1.87 | -1.73 | -1.92 | |
Current ratio | 4.65 | 4.34 | 4.19 | 4.7 | 5.16 | |
Interest coverage | 6.3 | 9.62 | 8.51 | 6.44 | 5.77 | |
Income quality | 1.07 | 1 | 0.86 | 2.13 | 1.08 | |
Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0.55 | 0 | 0 | 0.8 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | -0.03 | -0.04 | -0.06 | 0.39 | 0.46 | |
Capex to operating cash flow | -0.9 | -0.22 | -0.21 | -0.5 | -0.24 | |
Capex to revenue | -0.22 | -0.09 | -0.06 | -0.25 | -0.1 | |
Capex to depreciation | -14.48 | -0.72 | -0.54 | -2.3 | -0.93 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 241.51 | 321.54 | 297.44 | 264.09 | 338.38 | |
ROIC | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | |
Graham Net | -0.48 | 1.51 | -2.17 | 8.26 | 15.17 | |
Working capital | 9619.97B | 9510.72B | 9332.28B | 9865.41B | 10523.29B | |
Tangible asset value | 21745.88B | 22693.6B | 23443.13B | 9501.87B | 7757.62B | |
Net current asset value | 2369.56B | 2505.13B | 2338.93B | 2620.96B | 3139.97B | |
Invested capital | 0.36 | 0.34 | 0.33 | 0.33 | 0.32 | |
Average receivables | 216.66B | 224.38B | 223.39B | 665.95B | 683.68B | |
Average payables | 143.17B | 229.95B | 229.33B | 208.2B | 202.8B | |
Average inventory | 3771.41B | 3807.83B | 3854.94B | 3883.6B | 4031.34B | |
Days sales outstanding | 13.79 | 14.31 | 13.49 | 59.47 | 14.46 | |
Days payables outstanding | 30.07 | 34.89 | 29.71 | 23.65 | 23.9 | |
Days of inventory on hand | 534 | 541.65 | 543.91 | 449.57 | 496.15 | |
Receivables turnover | 6.53 | 6.29 | 6.67 | 1.51 | 6.22 | |
Payables turnover | 2.99 | 2.58 | 3.03 | 3.81 | 3.77 | |
Inventory turnover | 0.17 | 0.17 | 0.17 | 0.2 | 0.18 | |
ROE | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | |
Capex per share | -6.92 | -2.7 | -1.89 | -8.61 | -3.3 |
PWON.JK Frequently Asked Questions
What is PT Pakuwon Jati Tbk stock symbol ?
PT Pakuwon Jati Tbk is a ID stock and trading under the symbol PWON.JK
What is PT Pakuwon Jati Tbk stock quote today ?
PT Pakuwon Jati Tbk stock price is $392 today.
Is PT Pakuwon Jati Tbk stock public?
Yes, PT Pakuwon Jati Tbk is a publicly traded company.